(Q48091798)

8 February 2018

title

Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia (English)

1 reference

8 February 2018

1 reference

1 reference

2

Siesjö BK

1 reference

8 February 2018

author name string

Yoshimoto T

series ordinal

1

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

8 February 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

8 February 2018

volume

839

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

283-291

1 reference

8 February 2018

Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Increased blood-brain permeability with hyperosmolar mannitol increases cerebral O2 consumption and O2 supply/consumption heterogeneity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

A critical evaluation of the principles governing the advantages of intra-arterial infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Mechanisms by which mitochondria transport calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

The mechanism of action of cyclosporin A and FK506.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Use of mild intraischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Delayed treatment with alpha-phenyl-N-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

FK506 and ciclosporin: molecular probes for studying intracellular signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Reversible middle cerebral artery occlusion without craniectomy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

The Effect of Mannitol on Experimental Cerebral Ischemia, Revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Immunosupressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Opening of the blood-brain barrier by acute hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Cyclosporin A protects against ischemia-reperfusion injury in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Effect of mannitol on local cerebral blood flow after temporary complete cerebral ischemia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Delayed treatment with the spin trap alpha-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

The mitochondrial permeability transition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

Quantification and pharmacokinetics of blood-brain barrier disruption in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901733-3

10.1016/S0006-8993(99)01733-3

7 January 2021

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018